Equities

Mercator Medical SA

Mercator Medical SA

Actions
  • Price (EUR)9.64
  • Today's Change0.01 / 0.10%
  • Shares traded60.00
  • 1 Year change+7.59%
  • Beta--
Data delayed at least 15 minutes, as of May 09 2024 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mercator Medical SA is a Poland-based company engaged in medical supplies industry. The Company manufactures medical gloves and distributes disposable medical materials. It produces medical, latex, synthetic, surgical, diagnostic sterile, examination and protective and household gloves. Its dressing products line includes gauze dressing products, non-woven fabric dressing, medical adhesive tapes, surgical dressing, among others. In addition, the Company provides drapes such as bed sheets, sets, as well as apparel, including caps, masks, gowns, among others. It operates through subsidiaries: Mercator Medical Kft, Mercator Medical srl, Merkator Medikal TOB, Mercator Medical (Thailand) Ltd and VIVOFT LLP.

  • Revenue in PLN (TTM)469.82m
  • Net income in PLN-232.16m
  • Incorporated2001
  • Employees1.29k
  • Location
    Mercator Medical SAHeleny Modrzejewskiej 30KRAKOW 31-327PolandPOL
  • Phone+48 126655400
  • Fax+48 126655415
  • Websitehttps://mercatormedical.eu/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.